This was necessary since hypokalemia (low potassium levels) is a common side effect of lapatinib (60), caused by excessive phosphorylation of hERG potassium channels (61), which may result in cardiac toxicity (62). This evidence concerns the gene KCNA3 and Hypokalemia.